harpoontx.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: Crawl-delay: | ||
Meta Tags
| Title | Harpoon Therapeutics | Immuno-oncology | |
| Description | Harpoon Therapeutics is an immuno-oncology company using a proprietary technology platform focused on T cell engagement to discover and develop novel biologics for the treatment of cancer and other |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 69.63.140.80 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
harpoontx.com Valuation
|
US$16,961,644
Last updated: 2023-05-01 05:56:49
harpoontx.com has Semrush global rank of 624,014. harpoontx.com has an estimated worth of US$ 16,961,644, based on its estimated Ads revenue. harpoontx.com receives approximately 1,957,113 unique visitors each day. Its web server is located in United States, with IP address 69.63.140.80. According to SiteAdvisor, harpoontx.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$16,961,644 |
| Daily Ads Revenue | US$15,657 |
| Monthly Ads Revenue | US$469,708 |
| Yearly Ads Revenue | US$5,636,485 |
| Daily Unique Visitors | 130,475 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| harpoontx.com. | A | 599 | IP: 69.63.140.80 |
| harpoontx.com. | NS | 3600 | NS Record: ns35.domaincontrol.com. |
| harpoontx.com. | NS | 3600 | NS Record: ns36.domaincontrol.com. |
| harpoontx.com. | MX | 600 | MX Record: 0 mx2-us1.ppe-hosted.com. |
| harpoontx.com. | MX | 600 | MX Record: 3 harpoontx-com.mail.protection.outlook.com. |
| harpoontx.com. | MX | 600 | MX Record: 0 mx1-us1.ppe-hosted.com. |
| harpoontx.com. | TXT | 600 | TXT Record: ppe-a626444f5a385dc71245 |
| harpoontx.com. | TXT | 600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
| harpoontx.com. | TXT | 600 | TXT Record: v=verifydomain MS=6783331 |
| harpoontx.com. | TXT | 600 | TXT Record: adobe-sign-verification=4cc2311399fe2d311b437921c3932e55 |
HtmlToTextCheckTime:2023-05-01 05:56:49
| --> Spearheading Immunotherapies TriTAC ® Technology Watch our TriTAC technology unleash the target cell-killing properties of a patient’s own immune system. Science Harpoon has created a novel antibody-based drug discovery platform called TriTAC ® , which offers a new way to unleash the target cell-killing properties of a patient’s own immune system. Learn More Careers Harpoon is seeking energetic, passionate scientists and innovators to join our effort. Learn More Recent News April 18, 2023 Harpoon Therapeutics Presents Preclinical Results for Novel T Cell Engagers HPN217 and HPN328 at AACR 2023 April 17, 2023 Harpoon Therapeutics Presents Data for New ProTriTAC™ Development Candidates in TROP2- and ITGB6-expressing Solid Tumors at AACR 2023 More News About Management Team Board of Directors Scientific Advisory Board Partners Science Publications Pipeline Expanded Access Policy Investors News Releases Events & Presentations Stock Information Corporate Governance SEC Filings IR |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Sat, 23 Oct 2021 21:47:42 GMT Server: Apache Location: https://www.harpoontx.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 200 OK Date: Sat, 23 Oct 2021 21:47:43 GMT Server: Apache Vary: User-Agent,Accept-Encoding ETag: 43a428 Cache-Control: max-age=30, s-maxage=30 Expires: Sat, 23 Oct 2021 21:48:13 GMT X-Frame-Options: SAMEORIGIN X-Content-Type-Options: nosniff X-XSS-Protection: 1; mode=block Strict-Transport-Security-Test: max-age=60 Strict-Transport-Security: max-age=15768000 Content-Security-Policy: default-src 'self' data:; report-uri /csp.cfm; style-src 'self' 'unsafe-inline' fonts.googleapis.com *.typekit.net; font-src 'self' data: https:; frame-ancestors 'self' https://harpoontx.jostle.us; frame-src 'self' player.vimeo.com *.youtube.com www.google.com; script-src 'self' 'unsafe-eval' 'unsafe-inline' ajax.googleapis.com www.google-analytics.com; img-src 'self' data: www.google-analytics.com https://*.vimeocdn.com; connect-src 'self' www.google-analytics.com Content-Type: text/html;charset=UTF-8 |
harpoontx.com Whois Information
Domain Name: HARPOONTX.COM Registry Domain ID: 1888782606_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2018-12-05T18:14:19Z Creation Date: 2014-12-05T02:41:04Z Registry Expiry Date: 2021-12-05T02:41:04Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS35.DOMAINCONTROL.COM Name Server: NS36.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-12T07:05:42Z <<< |